Cargando…

Management of Hepatocellular Carcinoma in Decompensated Cirrhotic Patients: A Comprehensive Overview

SIMPLE SUMMARY: Decompensated patients with hepatocellular carcinoma (HCC) are a wide patient category with limited therapeutic options, and are often excluded from existing trials. Liver transplantation is the best treatment option for such patients but is affected by strict selection criteria and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tampaki, Maria, Papatheodoridis, George V., Cholongitas, Evangelos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954723/ https://www.ncbi.nlm.nih.gov/pubmed/36831651 http://dx.doi.org/10.3390/cancers15041310

Ejemplares similares

The changing epidemiology of hepatocellular carcinoma in Greece
por: Markakis, George E., et al.
Publicado: (2022)

Clinical impact of microbiome in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2018)

The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2020)

The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis
por: Cholongitas, Evangelos, et al.
Publicado: (2015)

Aspartate aminotransferase-to-platelet ratio index can predict the outcome in patients with stable decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2023)

Sofosbuvir: a novel oral agent for chronic hepatitis C
por: Cholongitas, Evangelos, et al.
Publicado: (2014)

New prognostic score based on galectin-3 has similar performance to model for end-stage liver disease and sodium score in patients with stable decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2021)

Hepatopulmonary syndrome is associated with the presence of hepatocellular carcinoma in patients with decompensated cirrhosis
por: Soulaidopoulos, Stergios, et al.
Publicado: (2017)

Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation
por: Cholongitas, Evangelos, et al.
Publicado: (2017)

Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
por: Desai, Aakash, et al.
Publicado: (2019)

An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians
por: Cespiati, Annalisa, et al.
Publicado: (2023)

Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients
por: Moriya, Kei, et al.
Publicado: (2019)

Frailty in metabolic syndrome, focusing on nonalcoholic fatty liver disease
por: Karakousis, Nikolaos D., et al.
Publicado: (2022)

The Management of Postoperative Cognitive Dysfunction in Cirrhotic Patients: An Overview of the Literature
por: Ingustu, Daiana-Georgiana, et al.
Publicado: (2023)

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
por: Varbobitis, Ioannis, et al.
Publicado: (2016)

Antiviral Therapy in HCV-infected Decompensated Cirrhotics
por: Danish, Fazal A., et al.
Publicado: (2010)

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma
por: Zanetto, Alberto, et al.
Publicado: (2018)

Blood Microbiome Quantity and the Hyperdynamic Circulation in Decompensated Cirrhotic Patients
por: Traykova, Daniela, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link
por: Chrysavgis, Lampros, et al.
Publicado: (2022)

High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2017)

Managing liver cirrhotic complications: Overview of esophageal and gastric varices
por: Lesmana, Cosmas Rinaldi Adithya, et al.
Publicado: (2020)

Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review
por: Cholongitas, Evangelos, et al.
Publicado: (2018)

Fondaparinux is effective for acute portal vein thrombosis in decompensated cirrhotic patients
por: Zhang, Zhi-Hao, et al.
Publicado: (2017)

Preoperative Evaluation of Coronary Artery Disease in Liver Transplant Candidates: Many Unanswered Questions in Clinical Practice
por: Bonou, Maria, et al.
Publicado: (2021)

Surveillance of hepatocellular carcinoma in cirrhotic patients: Current knowledge and future directions
por: Demirtas, Coskun Ozer, et al.
Publicado: (2020)

Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma
por: Bousali, Maria, et al.
Publicado: (2021)

Nutritional Deficiencies and Clinical Practices in Decompensated Cirrhotics With Hepatic Encephalopathy
por: Panchani, Nishah N, et al.
Publicado: (2022)

Impact of direct-acting antiviral agents on the development of hepatocellular carcinoma: evidence and pathophysiological issues
por: Tampaki, Maria, et al.
Publicado: (2018)

Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma
por: Liu, Yan, et al.
Publicado: (2017)

Significance of Circulating Cell-Free DNA Species in Non-Alcoholic Fatty Liver Disease
por: Chrysavgis, Lampros, et al.
Publicado: (2021)

Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
por: Yen, Fu‐Shun, et al.
Publicado: (2021)

Pulmonary manifestations of chronic liver disease: a comprehensive review
por: Soulaidopoulos, Stergios, et al.
Publicado: (2020)

Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma
por: Kondo, Takayuki, et al.
Publicado: (2022)

Management of Cholelithiasis in Cirrhotic Patients
por: Francesca, Viscosi, et al.
Publicado: (2022)

Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
por: Tampaki, Maria, et al.
Publicado: (2020)

Hepatocellular Carcinoma Arising in Non-Cirrhotic Haemochromatosis
por: Thompson, N. P., et al.
Publicado: (1995)

Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers
por: Renzulli, Matteo, et al.
Publicado: (2022)

The Impact of Previous Acute Decompensation on the Long-Term Prognosis of Alcoholic Hepatitis in Cirrhotic Patients
por: Yoon, Eileen L., et al.
Publicado: (2019)

Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma
por: Donaires, Flávia S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cofbjv3dup9he4ccc844lrhgqd